Phenylketonuria Flashcards
What type of disorder is phenylketonuria
Inherited metabolic disorder
Cause of phenylketonuria
Absence of an enzyme
Treatment strategy for inherited metabolic disorders
• supplymissingproduct
• restrictintakeofsubstrate
• increaseexcretionoftoxicproducts • replacethemissingenzyme
• replacetheabnormalgene
What enzyme is deficient in phenylketonuria
Phenylalanine hydroxylase
What type of inherited disorder is it
Autosomal recessive
Incidence ratio
1;10,000 births
Functions of Tyrosine
Used to synthesize:
• tissue proteins • melanin
• thyroxine
• catecholamines
Clinical Features of PKU
• vomiting
• irritability
• poor feeding
• pale skin
• eczema
• blue eyes
• fair hair
• mental retardation
Hyperphenylalaninaemia
High serum [phenylalanine] causes brain damage by:
• interfering with brain amino acid metabolism
• inhibition of neurotransmitter release
Diagnosis of PKU
High serum [phenylalanine ] levels; • >700 μmol/L (normal <100 μmol/L)
Management of PKU
-Restrict dietary intake of phenylalanine Ensure -adequate tyrosine intake
-Treatment should ensure following limits:
0-5 years - <360 μmol/L
5-10 years - <480 μmol/L
10+ years - <700 μmol/L
Monitoring of PKU Treatment
Monitoring of treatment advisable in:
• newly diagnosed infants with PKU • pregnant females with PKU
Difficulties with screening for inherited disease
• does disease have a relatively high incidence?
• can disease be detected within days of birth?
• can disease be identified by a biochemical marker which can be easily measured?
• will disease be missed clinically, and would this cause irreversible damage to the baby?
• can disease be treated and will result of screening test be available before any irreversible damage occurs to baby?
• is screening programme cost effective?
Screening for PKU
Capillary blood specimen collected 6-10 days after birth:
[phenylalanine] determined by:
• Guthrie test
• thin layer chromatography
• fluorimetric method
• mass spectrometry
Guthrie Method for PKU
• semiquantitativemicrobiologicalassayusing Bacillus subtilis
• sporesincorporatedintoagarmedium containing β-2-thienylalanine
• filterdiscscontainingbloodfrompatients placed on agar plate
• zonesofbacterialgrowtharounddiscfrom PKU patients